LDL cholesterol apheresis treatment for diabetic nephropathy with severe urinary protein-Observational Study

LICENSE-Observational Study - LICENSE-ON

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047516

Enrollment

150

Registered

2022-04-18

Start date

2020-06-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic nephropathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Advanced medical care A Patients who have been treated according to the provisions of "LDL apheresis therapy". Includes participants in the LICENSE study (jRCTs042180076).

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
Introduced maintenance dialysis	—

Countries

Japan

Contacts

Public ContactAkihiko Koshino

Kanazawa University Department of Nephrology and Laboratory Medicine

koshino1307@gmail.com076-265-2000

Outcome results